Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001104659-22-001475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-05 | 2022-01-03+ | HRMY | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $45.16 | -28.7K | 0 | -100% | -$1.30M |
| DM | 2022-01-05 | 2022-01-03+ | HRMY | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +28.7K | 18.1K | New | +$235.9K |
| DM | 2022-01-05 | 2022-01-03+ | HRMY | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | -28.7K | 234.8K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | S | D | 10,647 | $45.17 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.37. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2022-01-03 | M | A | 10,647 | $8.22 | 10,647 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-04 | M | A | 18,053 | $8.22 | 18,053 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-04 | S | D | 18,053 | $45.15 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.70. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Stock Option | 2022-01-03 | M | D | 10,647 | $0.00 | 252,804 | D | $8.22 · — to 2027-10-02 | 10,647 Common Stock | (F4) The stock option is currently vested with respect to 251,801 shares, and will vest with respect to the remainder of the shares on October 1, 2022. |
| 6 | Derivative | Stock Option | 2022-01-04 | M | D | 18,053 | $0.00 | 234,751 | D | $8.22 · — to 2027-10-02 | 18,053 Common Stock | (F4) The stock option is currently vested with respect to 251,801 shares, and will vest with respect to the remainder of the shares on October 1, 2022. |